glp-1 obesity drugs pipeline Top and Diabetes Medications Transforming U.S. Pharma Market Oral GLP-1-Based Therapeutics in the

Giugliano D, Scappaticcio L, Longo M, et al

Examples include AstraZenecas investment in Eccogene and Roches agreement to buy GLP-1 drug developer Carmot Therapeutics for up to $3.1bn in December 2023

doi:10.6061/clinics/2015(11)09

Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes

Below are the current list prices for a one-month supply of popular GLP-1s: Zepbound single-dose pens: $1,086.37 Zepbound vials : $299$449 Mounjaro: $1,079.77 Ozempic: $997.58 Wegovy: $1,349.02 or $199$349 (cash price) Saxenda: $1,349.02 If your insurance does cover weight loss medications, manufacturer savings programs may help reduce these costs significantly